PHILADELPHIA and LONDON, May 18 /CNW/ -- The Healthcare and Science
business of Thomson Reuters today announced the results of a study assessing
influential research in bioterrorism from 1999 to 2008. The findings appear
in the May/June issue of Science Watch (www.sciencewatch.com) and are based on
more than 12,000 bioterrorism-related papers published in Thomson
Reuters-indexed journals during this time period.
Science Watch ranked the top 25 institutions by both total citations and
citation impact (average citations per paper). The United States accounts for
23 of the top 25 institutions in both total citations and citation impact.
The U. S. Army took the top spot in total citations with an impressive 9,637
citations to its researchers' work. The U. S. Centers for Disease Control and
Prevention ranked second with 6,912 citations, and Johns Hopkins University
with 5,006 citations ranked third.
U. S. institutions also led the pack in citation impact, a measure of
average citations per published paper. The Institute for Genomic Research had
an impact of 62.64 and the New York City Department of Health had an impact of
57.06. Claiming the third spot was the Imperial College of London with an
impact of 31.55.
The most cited bioterrorism paper was published in 2001, regarding the
causative agent of plague, Yersinia pestis; this paper has been cited nearly
500 times. The second most cited paper, entitled "Anthrax," was published
two years before anthrax-tainted mail killed five people in 2001; this paper
has now been cited more than 400 times. The third most-cited paper, published
in 1999 and garnering more than 375 citations, discusses the use of smallpox
as a biological weapon.
For the complete rankings of total citations and citation impact in the
bioterrorism field, as well as a rundown of the most cited individual
bioterrorism researchers during the time period, visit ScienceWatch.com.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information
for businesses and professionals. We combine industry expertise with
innovative technology to deliver critical information to leading decision
makers in the financial, legal, tax and accounting, scientific, healthcare and
media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs more than 50,000 people in 93 countries. For more
information, go to www.thomsonreuters.com.
For further information:
For further information: Sue Besaw, Healthcare and Science of Thomson
Reuters, +1-215-823-1840, firstname.lastname@example.org Web Site: